Redhill Biopharma Ltd (NASDAQ:RDHL)

7.31
Delayed Data
As of Apr 09
 +0.60 / +8.94%
Today’s Change
5.79
Today|||52-Week Range
11.52
-9.53%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$338.8M

Company Description

RedHill Biopharma Ltd. is a biopharmaceutical company focusing gastrointestinal and infectious diseases. It operates through the following segments: Commercial Operations and the Research & Development. The Commercial Operations segment covers all areas relating to the commercial sales and operating expenses directly related to that activity and is being performed by the Company's subsidiary in the United States. The Research & Development segment includes all activities related to the research and development of therapeutic candidates. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.

Contact Information

RedHill Biopharma Ltd.
21 Ha'arba'a Street
Tel Aviv Tel Aviv 6473921
P:(723) 541-3131
Investor Relations:

Employees

Shareholders

Other institutional9.42%
Mutual fund holders6.52%
Individual stakeholders--

Top Executives

Dror Ben-AsherChairman & Chief Executive Officer
Gilead RadayChief Operating Officer
Micha Ben-ChorinChief Financial Officer
Reza FathiSenior Vice President-Research & Development
June Sherie AlmenoffChief Scientific Officer